| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2241aa1044fb0713119bc64b16ae7d33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate |
2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d10935c7cbc6dcd3edf7e588442094dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55d80d321334de2e010177c32eec1140 |
| publicationDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016008435-A1 |
| titleOfInvention |
Composition for preventing or treating b-cell lymphoma comprising il-21 expressing mesenchymal stem cells |
| abstract |
Provided is a pharmaceutical composition for preventing or treating B-cell lymphoma including IL-21 expressing mesenchymal stem cells, and a treating method using the same. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419898-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10993967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018191619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446332-B2 |
| priorityDate |
2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |